首页 > 最新文献

Frontiers of Medicine最新文献

英文 中文
Erratum to: Identification of susceptibility loci and relevant cell type for IgA nephropathy in Han Chinese by integrative genome-wide analysis. 通过整合全基因组分析鉴定中国人IgA肾病的易感位点和相关细胞类型。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 DOI: 10.1007/s11684-024-1121-3
Ming Li, Xingjie Hao, Dianchun Shi, Shanshan Cheng, Zhong Zhong, Lu Cai, Minghui Jiang, Lin Ding, Lanbo Ding, Chaolong Wang, Xueqing Yu
{"title":"Erratum to: Identification of susceptibility loci and relevant cell type for IgA nephropathy in Han Chinese by integrative genome-wide analysis.","authors":"Ming Li, Xingjie Hao, Dianchun Shi, Shanshan Cheng, Zhong Zhong, Lu Cai, Minghui Jiang, Lin Ding, Lanbo Ding, Chaolong Wang, Xueqing Yu","doi":"10.1007/s11684-024-1121-3","DOIUrl":"10.1007/s11684-024-1121-3","url":null,"abstract":"","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"1119"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142846021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament. 单细胞转录组分析确定了骨化后纵韧带中 I 型干扰素信号的激活。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-10-23 DOI: 10.1007/s11684-024-1075-5
Xiao Liu, Lei Zhang, Ge Wang, Wei Zhao, Chen Liang, Youzhi Tang, Yenan Fu, Bo Liu, Jing Zhang, Xiaoguang Liu, Hongquan Zhang, Yu Yu

Ossification of the posterior longitudinal ligament (OPLL) is a condition comprising ectopic bone formation from spinal ligaments. This disease is a leading cause of myelopathy in the Asian population. However, the molecular mechanism underlying OPLL and efficient preventive interventions remain unclear. Here, we performed single-cell RNA sequencing and revealed that type I interferon (IFN) signaling was activated in the ossified ligament of patients with OPLL. We also observed that IFN-β stimulation promoted the osteogenic differentiation of preosteoblasts in vitro and activated the ossification-related gene SPP1, thereby confirming the single-cell RNA sequencing findings. Further, blocking the IFN-α/β subunit 1 receptor (IFNAR1) using an anti-IFNAR1 neutralizing antibody markedly suppressed osteogenic differentiation. Together, these results demonstrated that the type I IFN signaling pathway facilitated ligament ossification, and the blockade of this signaling might provide a foundation for the prevention of OPLL.

后纵韧带骨化症(OPLL)是一种由脊柱韧带异位骨形成的疾病。这种疾病是亚洲人脊髓病的主要病因。然而,OPLL 的分子机制和有效的预防干预措施仍不清楚。在此,我们进行了单细胞 RNA 测序,发现 OPLL 患者骨化韧带中的 I 型干扰素(IFN)信号被激活。我们还观察到,IFN-β刺激可促进体外前成骨细胞的成骨分化,并激活骨化相关基因SPP1,从而证实了单细胞RNA测序的结果。此外,使用抗 IFNAR1 中和抗体阻断 IFN-α/β 亚基 1 受体(IFNAR1)可明显抑制成骨分化。这些结果共同表明,I型IFN信号通路促进了韧带骨化,而阻断这种信号通路可能为预防OPLL奠定基础。
{"title":"Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament.","authors":"Xiao Liu, Lei Zhang, Ge Wang, Wei Zhao, Chen Liang, Youzhi Tang, Yenan Fu, Bo Liu, Jing Zhang, Xiaoguang Liu, Hongquan Zhang, Yu Yu","doi":"10.1007/s11684-024-1075-5","DOIUrl":"10.1007/s11684-024-1075-5","url":null,"abstract":"<p><p>Ossification of the posterior longitudinal ligament (OPLL) is a condition comprising ectopic bone formation from spinal ligaments. This disease is a leading cause of myelopathy in the Asian population. However, the molecular mechanism underlying OPLL and efficient preventive interventions remain unclear. Here, we performed single-cell RNA sequencing and revealed that type I interferon (IFN) signaling was activated in the ossified ligament of patients with OPLL. We also observed that IFN-β stimulation promoted the osteogenic differentiation of preosteoblasts in vitro and activated the ossification-related gene SPP1, thereby confirming the single-cell RNA sequencing findings. Further, blocking the IFN-α/β subunit 1 receptor (IFNAR1) using an anti-IFNAR1 neutralizing antibody markedly suppressed osteogenic differentiation. Together, these results demonstrated that the type I IFN signaling pathway facilitated ligament ossification, and the blockade of this signaling might provide a foundation for the prevention of OPLL.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"1087-1099"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study. 新诊断的同源重组缺陷阳性/BRCA野生型卵巢癌患者接受奥拉帕利维持治疗的首个证据:真实世界多中心研究。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-11-06 DOI: 10.1007/s11684-024-1083-5
Jing Li, Youguo Chen, Mian He, Xiaoxiang Chen, Hao Wen, Yu Kang, Kaijiang Liu, Ge Lou, Xipeng Wang, Qinglian Wen, Li Wang, Zhongqiu Lin

Although olaparib has demonstrated substantial clinical benefits as maintenance therapy in BRCA mutation-carrying women with newly diagnosed advanced ovarian cancer, its effectiveness in patients without BRCA mutations remains poorly investigated. This study aims to provide the first evidence on the efficacy of mono-olaparib maintenance therapy in such context. Using real-world data from 11 high-volume tertiary care centers in China, a retrospective cohort study was conducted to assess the efficacy and safety of olaparib as first-line maintenance therapy in patients with BRCA wild-type ovarian cancer. The primary objective was 1-year progression-free survival rate. Safety was also evaluated. Fifty patients with a median age of 54 years were included, and all of them tested negative for BRCA mutations but positive for homologous recombination deficiency (HRD). The 1-year PFS rate was 75.2% (95% CI, 63.4 to 89.2), and the median PFS was 21.0 months (95% CI, 13.8 to 28.2). All the patients received olaparib at a starting dose of 300 mg twice daily, and none experienced serious adverse events (AEs). Eight (16%) patients had dose adjustment, but none discontinued olaparib treatment due to AEs. We provide the first evidence that mono-olaparib could be a safe and effective maintenance treatment option for patients newly diagnosed with HRD-positive/BRCA wild-type ovarian cancer.

尽管奥拉帕利作为维持疗法对携带 BRCA 基因突变的新诊断晚期卵巢癌妇女有很大的临床疗效,但其对无 BRCA 基因突变患者的疗效研究仍然很少。本研究旨在为单药奥拉帕利维持治疗在这种情况下的疗效提供第一手证据。本研究利用来自中国11个高容量三级医疗中心的真实数据,开展了一项回顾性队列研究,以评估奥拉帕利作为BRCA野生型卵巢癌患者一线维持治疗的有效性和安全性。研究的主要目标是1年无进展生存率。同时还评估了安全性。研究共纳入了50名患者,中位年龄为54岁,所有患者的BRCA基因突变检测结果均为阴性,但同源重组缺陷(HRD)检测结果均为阳性。1年PFS率为75.2%(95% CI,63.4至89.2),中位PFS为21.0个月(95% CI,13.8至28.2)。所有患者接受的奥拉帕利起始剂量均为300毫克,每天两次,没有人出现严重不良事件(AE)。8名(16%)患者进行了剂量调整,但没有人因不良反应而中断奥拉帕利的治疗。我们首次提供了证据,证明单奥拉帕利是新诊断为HRD阳性/BRCA野生型卵巢癌患者的一种安全有效的维持治疗方案。
{"title":"First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study.","authors":"Jing Li, Youguo Chen, Mian He, Xiaoxiang Chen, Hao Wen, Yu Kang, Kaijiang Liu, Ge Lou, Xipeng Wang, Qinglian Wen, Li Wang, Zhongqiu Lin","doi":"10.1007/s11684-024-1083-5","DOIUrl":"10.1007/s11684-024-1083-5","url":null,"abstract":"<p><p>Although olaparib has demonstrated substantial clinical benefits as maintenance therapy in BRCA mutation-carrying women with newly diagnosed advanced ovarian cancer, its effectiveness in patients without BRCA mutations remains poorly investigated. This study aims to provide the first evidence on the efficacy of mono-olaparib maintenance therapy in such context. Using real-world data from 11 high-volume tertiary care centers in China, a retrospective cohort study was conducted to assess the efficacy and safety of olaparib as first-line maintenance therapy in patients with BRCA wild-type ovarian cancer. The primary objective was 1-year progression-free survival rate. Safety was also evaluated. Fifty patients with a median age of 54 years were included, and all of them tested negative for BRCA mutations but positive for homologous recombination deficiency (HRD). The 1-year PFS rate was 75.2% (95% CI, 63.4 to 89.2), and the median PFS was 21.0 months (95% CI, 13.8 to 28.2). All the patients received olaparib at a starting dose of 300 mg twice daily, and none experienced serious adverse events (AEs). Eight (16%) patients had dose adjustment, but none discontinued olaparib treatment due to AEs. We provide the first evidence that mono-olaparib could be a safe and effective maintenance treatment option for patients newly diagnosed with HRD-positive/BRCA wild-type ovarian cancer.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"1026-1034"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChromTR: chromosome detection in raw metaphase cell images via deformable transformers. ChromTR:通过变形变压器在原始中期细胞图像中检测染色体。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-12-07 DOI: 10.1007/s11684-024-1098-y
Chao Xia, Jiyue Wang, Xin You, Yaling Fan, Bing Chen, Saijuan Chen, Jie Yang

Chromosome karyotyping is a critical way to diagnose various hematological malignancies and genetic diseases, of which chromosome detection in raw metaphase cell images is the most critical and challenging step. In this work, focusing on the joint optimization of chromosome localization and classification, we propose ChromTR to accurately detect and classify 24 classes of chromosomes in raw metaphase cell images. ChromTR incorporates semantic feature learning and class distribution learning into a unified DETR-based detection framework. Specifically, we first propose a Semantic Feature Learning Network (SFLN) for semantic feature extraction and chromosome foreground region segmentation with object-wise supervision. Next, we construct a Semantic-Aware Transformer (SAT) with two parallel encoders and a Semantic-Aware decoder to integrate global visual and semantic features. To provide a prediction with a precise chromosome number and category distribution, a Category Distribution Reasoning Module (CDRM) is built for foreground-background objects and chromosome class distribution reasoning. We evaluate ChromTR on 1404 newly collected R-band metaphase images and the public G-band dataset AutoKary2022. Our proposed ChromTR outperforms all previous chromosome detection methods with an average precision of 92.56% in R-band chromosome detection, surpassing the baseline method by 3.02%. In a clinical test, ChromTR is also confident in tackling normal and numerically abnormal karyotypes. When extended to the chromosome enumeration task, ChromTR also demonstrates state-of-the-art performances on R-band and G-band two metaphase image datasets. Given these superior performances to other methods, our proposed method has been applied to assist clinical karyotype diagnosis.

染色体核型是诊断各种血液学恶性肿瘤和遗传病的重要手段,其中中期细胞原始图像的染色体检测是最关键和最具挑战性的一步。在这项工作中,我们着眼于染色体定位和分类的联合优化,我们提出了ChromTR来准确地检测和分类中期细胞原始图像中的24类染色体。ChromTR将语义特征学习和类分布学习结合到统一的基于der的检测框架中。具体来说,我们首先提出了一种语义特征学习网络(SFLN),用于语义特征提取和染色体前景区域分割。接下来,我们构建了一个具有两个并行编码器和一个语义感知解码器的语义感知转换器(SAT),以集成全局视觉和语义特征。为了提供精确的染色体数目和类别分布预测,构建了一个类别分布推理模块(CDRM),用于前景-背景对象和染色体类别分布推理。我们在1404张新收集的r波段中期图像和公开的g波段数据集AutoKary2022上评估了ChromTR。我们提出的ChromTR在r波段染色体检测中平均精度为92.56%,优于以往所有的染色体检测方法,比基线方法高出3.02%。在临床试验中,ChromTR在处理正常和数字异常核型方面也很有信心。当扩展到染色体枚举任务时,ChromTR在r波段和g波段两个中期图像数据集上也展示了最先进的性能。鉴于这些优于其他方法的性能,我们提出的方法已被应用于辅助临床核型诊断。
{"title":"ChromTR: chromosome detection in raw metaphase cell images via deformable transformers.","authors":"Chao Xia, Jiyue Wang, Xin You, Yaling Fan, Bing Chen, Saijuan Chen, Jie Yang","doi":"10.1007/s11684-024-1098-y","DOIUrl":"10.1007/s11684-024-1098-y","url":null,"abstract":"<p><p>Chromosome karyotyping is a critical way to diagnose various hematological malignancies and genetic diseases, of which chromosome detection in raw metaphase cell images is the most critical and challenging step. In this work, focusing on the joint optimization of chromosome localization and classification, we propose ChromTR to accurately detect and classify 24 classes of chromosomes in raw metaphase cell images. ChromTR incorporates semantic feature learning and class distribution learning into a unified DETR-based detection framework. Specifically, we first propose a Semantic Feature Learning Network (SFLN) for semantic feature extraction and chromosome foreground region segmentation with object-wise supervision. Next, we construct a Semantic-Aware Transformer (SAT) with two parallel encoders and a Semantic-Aware decoder to integrate global visual and semantic features. To provide a prediction with a precise chromosome number and category distribution, a Category Distribution Reasoning Module (CDRM) is built for foreground-background objects and chromosome class distribution reasoning. We evaluate ChromTR on 1404 newly collected R-band metaphase images and the public G-band dataset AutoKary2022. Our proposed ChromTR outperforms all previous chromosome detection methods with an average precision of 92.56% in R-band chromosome detection, surpassing the baseline method by 3.02%. In a clinical test, ChromTR is also confident in tackling normal and numerically abnormal karyotypes. When extended to the chromosome enumeration task, ChromTR also demonstrates state-of-the-art performances on R-band and G-band two metaphase image datasets. Given these superior performances to other methods, our proposed method has been applied to assist clinical karyotype diagnosis.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"1100-1114"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunological face of megakaryocytes. 巨核细胞的免疫学面貌。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-11-14 DOI: 10.1007/s11684-024-1087-1
Yueying Li, Kunying Chen, Qian-Fei Wang

Megakaryocytes (MKs), which are traditionally known for their role in platelet production, are now emerging as unique immune cells with diverse capabilities. They express immune receptors, participate in pathogen recognition and response, phagocytose pathogens, contribute to antigen presentation, and interact with various immune cell types. When encountering inflammatory challenges, MKs exhibit intricate immune functions that can either promote or inhibit inflammation. These responses are mediated through mechanisms, such as the secretion of either anti-inflammatory or pro-inflammatory cytokines and release of immunomodulatory platelets according to specific conditions. This intricate array of responses necessitates a detailed exploration to determine whether the immune functions of MKs are carried out by the entire MK population or by a specific subpopulation. Breakthroughs in single-cell RNA sequencing have uncovered a unique "immune MK" subpopulation, revealing its distinct characteristics and immunoregulatory functions. This review provides latest insights into MKs' immune attributes and their roles in physiological and pathological contexts and emphasizes the discovery and functions of "immune MKs".

巨核细胞(MKs)传统上因其在血小板生成中的作用而为人所知,现在正逐渐成为具有多种功能的独特免疫细胞。它们表达免疫受体,参与病原体识别和反应,吞噬病原体,参与抗原递呈,并与各种免疫细胞类型相互作用。当遇到炎症挑战时,MKs 表现出复杂的免疫功能,既能促进炎症,也能抑制炎症。这些反应是通过一些机制介导的,如分泌抗炎或促炎细胞因子,以及根据特定条件释放免疫调节血小板。由于这些反应错综复杂,因此有必要进行详细研究,以确定 MK 的免疫功能是由整个 MK 群体还是由特定亚群执行的。单细胞 RNA 测序的突破性进展发现了一种独特的 "免疫 MK "亚群,揭示了其独特的特征和免疫调节功能。这篇综述对 MKs 的免疫属性及其在生理和病理环境中的作用提供了最新见解,并强调了 "免疫 MKs "的发现和功能。
{"title":"Immunological face of megakaryocytes.","authors":"Yueying Li, Kunying Chen, Qian-Fei Wang","doi":"10.1007/s11684-024-1087-1","DOIUrl":"10.1007/s11684-024-1087-1","url":null,"abstract":"<p><p>Megakaryocytes (MKs), which are traditionally known for their role in platelet production, are now emerging as unique immune cells with diverse capabilities. They express immune receptors, participate in pathogen recognition and response, phagocytose pathogens, contribute to antigen presentation, and interact with various immune cell types. When encountering inflammatory challenges, MKs exhibit intricate immune functions that can either promote or inhibit inflammation. These responses are mediated through mechanisms, such as the secretion of either anti-inflammatory or pro-inflammatory cytokines and release of immunomodulatory platelets according to specific conditions. This intricate array of responses necessitates a detailed exploration to determine whether the immune functions of MKs are carried out by the entire MK population or by a specific subpopulation. Breakthroughs in single-cell RNA sequencing have uncovered a unique \"immune MK\" subpopulation, revealing its distinct characteristics and immunoregulatory functions. This review provides latest insights into MKs' immune attributes and their roles in physiological and pathological contexts and emphasizes the discovery and functions of \"immune MKs\".</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"988-1001"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PAK5-mediated PKM2 phosphorylation is critical for anaerobic glycolysis in endometriosis. PAK5 介导的 PKM2 磷酸化对子宫内膜异位症中的无氧糖酵解至关重要。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.1007/s11684-024-1069-3
Jiayi Lu, Xiaoyun Wang, Xiaodan Shi, Junyi Jiang, Lan Liu, Lu Liu, Chune Ren, Chao Lu, Zhenhai Yu

P21-activated kinase 5 (PAK5) belongs to the PAK-II subfamily, which is an important regulator of cell survival, adhesion, and motility. However, the functions of PAK5 in endometriosis remain unclear. Here, PAK5 is strikingly upregulated in endometriosis. Furthermore, the knockdown of PAK5 or its inhibitor GNE 2861 blocks the development of endometriosis, which is equally demonstrated in PAK5-knockout mice. In addition, PAK5 promotes glycolysis by enhancing the protein stability of pyruvate kinase 2 (PKM2) in endometriotic cells, which is a key enzyme for glucose metabolism. Moreover, the phosphorylation of PKM2 at Ser519 by PAK5 mediates endometriosis cell proliferation and metastasis. Collectively, PAK5 plays an indispensable role in endometriosis. Our findings demonstrate that PAK5 is an important target for the treatment of endometriosis.

P21激活激酶5(PAK5)属于PAK-II亚家族,是细胞存活、粘附和运动的重要调节因子。然而,PAK5在子宫内膜异位症中的功能仍不清楚。在本研究中,PAK5在子宫内膜异位症中显著上调。此外,PAK5或其抑制剂GNE 2861的敲除可阻止子宫内膜异位症的发生,这一点在PAK5基因敲除小鼠中同样得到了证实。此外,PAK5 通过增强子宫内膜异位症细胞中丙酮酸激酶 2(PKM2)蛋白的稳定性来促进糖酵解,而丙酮酸激酶 2 是葡萄糖代谢的关键酶。此外,PAK5 使 PKM2 在 Ser519 处磷酸化,介导了子宫内膜异位症细胞的增殖和转移。总之,PAK5 在子宫内膜异位症中扮演着不可或缺的角色。我们的研究结果表明,PAK5 是治疗子宫内膜异位症的一个重要靶点。
{"title":"PAK5-mediated PKM2 phosphorylation is critical for anaerobic glycolysis in endometriosis.","authors":"Jiayi Lu, Xiaoyun Wang, Xiaodan Shi, Junyi Jiang, Lan Liu, Lu Liu, Chune Ren, Chao Lu, Zhenhai Yu","doi":"10.1007/s11684-024-1069-3","DOIUrl":"10.1007/s11684-024-1069-3","url":null,"abstract":"<p><p>P21-activated kinase 5 (PAK5) belongs to the PAK-II subfamily, which is an important regulator of cell survival, adhesion, and motility. However, the functions of PAK5 in endometriosis remain unclear. Here, PAK5 is strikingly upregulated in endometriosis. Furthermore, the knockdown of PAK5 or its inhibitor GNE 2861 blocks the development of endometriosis, which is equally demonstrated in PAK5-knockout mice. In addition, PAK5 promotes glycolysis by enhancing the protein stability of pyruvate kinase 2 (PKM2) in endometriotic cells, which is a key enzyme for glucose metabolism. Moreover, the phosphorylation of PKM2 at Ser519 by PAK5 mediates endometriosis cell proliferation and metastasis. Collectively, PAK5 plays an indispensable role in endometriosis. Our findings demonstrate that PAK5 is an important target for the treatment of endometriosis.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"1054-1067"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nipah virus: epidemiology, pathogenesis, treatment, and prevention. 尼帕病毒:流行病学、发病机制、治疗和预防。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-01 Epub Date: 2024-10-17 DOI: 10.1007/s11684-024-1078-2
Limei Wang, Denghui Lu, Maosen Yang, Shiqi Chai, Hong Du, Hong Jiang

Nipah virus (NiV) is a zoonotic paramyxovirus that has recently emerged as a crucial public health issue. It can elicit severe encephalitis and respiratory diseases in animals and humans, leading to fatal outcomes, exhibiting a wide range of host species tropism, and directly transmitting from animals to humans or through an intermediate host. Human-to-human transmission associated with recurrent NiV outbreaks is a potential global health threat. Currently, the lack of effective therapeutics or licensed vaccines for NiV necessitates the primary utilization of supportive care. In this review, we summarize current knowledge of the various aspects of the NiV, including therapeutics, vaccines, and its biological characteristics, epidemiology, pathogenesis, and clinical features. The objective is to provide valuable information from scientific and clinical research and facilitate the formulation of strategies for preventing and controlling the NiV.

尼帕病毒(NiV)是一种人畜共患的副粘病毒,最近已成为一个重要的公共卫生问题。它可在动物和人类中引发严重的脑炎和呼吸道疾病,导致致命后果,并表现出广泛的宿主物种趋性,可直接从动物传播给人类或通过中间宿主传播。反复爆发的 NiV 导致的人际传播是一种潜在的全球健康威胁。目前,由于缺乏针对 NiV 的有效疗法或已获许可的疫苗,因此必须以支持性护理为主。在这篇综述中,我们总结了目前关于 NiV 的各方面知识,包括治疗方法、疫苗及其生物特性、流行病学、发病机制和临床特征。目的是提供有价值的科学和临床研究信息,促进制定预防和控制尼罗河病毒的策略。
{"title":"Nipah virus: epidemiology, pathogenesis, treatment, and prevention.","authors":"Limei Wang, Denghui Lu, Maosen Yang, Shiqi Chai, Hong Du, Hong Jiang","doi":"10.1007/s11684-024-1078-2","DOIUrl":"10.1007/s11684-024-1078-2","url":null,"abstract":"<p><p>Nipah virus (NiV) is a zoonotic paramyxovirus that has recently emerged as a crucial public health issue. It can elicit severe encephalitis and respiratory diseases in animals and humans, leading to fatal outcomes, exhibiting a wide range of host species tropism, and directly transmitting from animals to humans or through an intermediate host. Human-to-human transmission associated with recurrent NiV outbreaks is a potential global health threat. Currently, the lack of effective therapeutics or licensed vaccines for NiV necessitates the primary utilization of supportive care. In this review, we summarize current knowledge of the various aspects of the NiV, including therapeutics, vaccines, and its biological characteristics, epidemiology, pathogenesis, and clinical features. The objective is to provide valuable information from scientific and clinical research and facilitate the formulation of strategies for preventing and controlling the NiV.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"969-987"},"PeriodicalIF":3.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent eosinophilia with a novel homozygous ARPC1B mutation. 复发性嗜酸性粒细胞增多伴新的纯合子ARPC1B突变。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1007/s11684-024-1106-2
Gamze Sonmez, Baris Ulum, Ates Kutay Tenekeci, Canan Caka, Ali Şahin, Alp Kazancıoğlu, Begum Ozbek, İsmail Yaz, Saliha Esenboğa, Deniz Çağdaş

Cytoskeletal network dysregulation is a pivotal determinant in various immunodeficiencies and autoinflammatory conditions. This report reviews the significance of actin remodeling in disease pathogenesis, focusing on the Arp2/3 complex and its regulatory subunit actin related protein 2/3 complex subunit 1B (ARPC1B). A spectrum of cellular dysfunctions associated with ARPC1B deficiency, impacting diverse immune cell types, is elucidated. The study presents a patient featuring recurrent and persistent eosinophilia attributed to homozygous ARPC1B mutation alongside concomitant compound heterozygous cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. We used ARPC1B antibody to stain the patient's peripheral blood lymphocytes and those of the control. The defect in the ARPC1B gene in the present patient caused absent/low expression by immunofluorescence microscopy. The intricate interplay between cytoskeletal defects and immunological manifestations underscores the complexity of disease phenotypes, warranting further exploration for targeted therapeutic strategies.

细胞骨架网络失调是各种免疫缺陷和自身炎症的关键决定因素。本文综述了肌动蛋白重塑在疾病发病机制中的意义,重点介绍了Arp2/3复合体及其调控亚基肌动蛋白相关蛋白2/3复合体亚基1B (ARPC1B)。与ARPC1B缺陷相关的一系列细胞功能障碍,影响多种免疫细胞类型,已被阐明。该研究报告了一名复发性和持续性嗜酸性粒细胞增多的患者,这是由于纯合性ARPC1B突变与伴随的复合杂合性囊性纤维化跨膜传导调节因子(CFTR)基因突变引起的。采用ARPC1B抗体对患者和对照组外周血淋巴细胞进行染色。本例患者ARPC1B基因缺陷导致免疫荧光显微镜下ARPC1B基因缺失或低表达。细胞骨架缺陷和免疫表现之间复杂的相互作用强调了疾病表型的复杂性,需要进一步探索靶向治疗策略。
{"title":"Recurrent eosinophilia with a novel homozygous ARPC1B mutation.","authors":"Gamze Sonmez, Baris Ulum, Ates Kutay Tenekeci, Canan Caka, Ali Şahin, Alp Kazancıoğlu, Begum Ozbek, İsmail Yaz, Saliha Esenboğa, Deniz Çağdaş","doi":"10.1007/s11684-024-1106-2","DOIUrl":"https://doi.org/10.1007/s11684-024-1106-2","url":null,"abstract":"<p><p>Cytoskeletal network dysregulation is a pivotal determinant in various immunodeficiencies and autoinflammatory conditions. This report reviews the significance of actin remodeling in disease pathogenesis, focusing on the Arp2/3 complex and its regulatory subunit actin related protein 2/3 complex subunit 1B (ARPC1B). A spectrum of cellular dysfunctions associated with ARPC1B deficiency, impacting diverse immune cell types, is elucidated. The study presents a patient featuring recurrent and persistent eosinophilia attributed to homozygous ARPC1B mutation alongside concomitant compound heterozygous cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. We used ARPC1B antibody to stain the patient's peripheral blood lymphocytes and those of the control. The defect in the ARPC1B gene in the present patient caused absent/low expression by immunofluorescence microscopy. The intricate interplay between cytoskeletal defects and immunological manifestations underscores the complexity of disease phenotypes, warranting further exploration for targeted therapeutic strategies.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study. 中国颈动脉斑块和动脉狭窄的患病率及相关风险因素:一项基于人群的研究。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-27 DOI: 10.1007/s11684-024-1088-0
Qingjia Zeng, Chongyang Zhang, Xinyao Liu, Shengmin Yang, Muyuan Ma, Jia Tang, Tianlu Yin, Shanshan Zhao, Wenjun Tu, Hongpu Hu

Stroke is a critical health issue in China, and carotid artery stenosis and plaque play key roles in its prevalence. Despite the acknowledged significance of this condition, detailed information regarding the prevalence of carotid artery stenosis and plaque across the Chinese population has been scarce. This study analyzed data from the China Stroke High-risk Population Screening and Intervention Program for 2020-2021, focusing on 194 878 Chinese adults aged 40 years and above. It assessed the prevalence of carotid artery stenosis and plaque and identified their associated risk factors. Results revealed a standardized prevalence of 0.40% for carotid artery stenosis and 36.27% for carotid plaque. Notably, the highest rates of stenosis were observed in north and south China at 0.61%, while southwestern China exhibited the highest plaque prevalence at 43.17%. Key risk factors included older age, male gender, hypertension, diabetes, stroke, smoking, and atrial fibrillation. This study highlights significant geographical and demographic disparities in the prevalence of these conditions, underlining the urgent need for targeted interventions and policy reforms. These measures are essential for reducing the incidence of stroke and improving patient outcomes, addressing this significant health challenge in China.

脑卒中在中国是一个严重的健康问题,而颈动脉狭窄和斑块在脑卒中发病率中起着关键作用。尽管这一疾病的重要性已得到公认,但有关中国人群颈动脉狭窄和斑块患病率的详细信息却很少。本研究分析了 2020-2021 年中国脑卒中高危人群筛查和干预项目的数据,重点关注 194 878 名 40 岁及以上的中国成年人。研究评估了颈动脉狭窄和斑块的患病率,并确定了与之相关的风险因素。结果显示,颈动脉狭窄的标准化患病率为 0.40%,颈动脉斑块的患病率为 36.27%。值得注意的是,华北和华南的颈动脉狭窄发生率最高,为 0.61%,而西南地区的颈动脉斑块发生率最高,为 43.17%。主要风险因素包括年龄偏大、男性、高血压、糖尿病、中风、吸烟和心房颤动。这项研究凸显了这些疾病的发病率在地域和人口方面的显著差异,强调了采取有针对性的干预措施和政策改革的迫切需要。这些措施对于降低脑卒中发病率、改善患者预后、应对中国这一重大健康挑战至关重要。
{"title":"Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study.","authors":"Qingjia Zeng, Chongyang Zhang, Xinyao Liu, Shengmin Yang, Muyuan Ma, Jia Tang, Tianlu Yin, Shanshan Zhao, Wenjun Tu, Hongpu Hu","doi":"10.1007/s11684-024-1088-0","DOIUrl":"https://doi.org/10.1007/s11684-024-1088-0","url":null,"abstract":"<p><p>Stroke is a critical health issue in China, and carotid artery stenosis and plaque play key roles in its prevalence. Despite the acknowledged significance of this condition, detailed information regarding the prevalence of carotid artery stenosis and plaque across the Chinese population has been scarce. This study analyzed data from the China Stroke High-risk Population Screening and Intervention Program for 2020-2021, focusing on 194 878 Chinese adults aged 40 years and above. It assessed the prevalence of carotid artery stenosis and plaque and identified their associated risk factors. Results revealed a standardized prevalence of 0.40% for carotid artery stenosis and 36.27% for carotid plaque. Notably, the highest rates of stenosis were observed in north and south China at 0.61%, while southwestern China exhibited the highest plaque prevalence at 43.17%. Key risk factors included older age, male gender, hypertension, diabetes, stroke, smoking, and atrial fibrillation. This study highlights significant geographical and demographic disparities in the prevalence of these conditions, underlining the urgent need for targeted interventions and policy reforms. These measures are essential for reducing the incidence of stroke and improving patient outcomes, addressing this significant health challenge in China.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer. 用于预测非小细胞肺癌预后的线粒体相关程序性细胞死亡模式。
IF 3.9 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-22 DOI: 10.1007/s11684-024-1093-3
Xueyan Shi, Sichong Han, Guizhen Wang, Guangbiao Zhou

Mitochondria are the convergence point of multiple pathways that trigger programmed cell death (PCD). Mitochondrial-associated PCD (mtPCD) is involved in the pathogenesis of several diseases. However, the role of mtPCD in the prognostic prediction of cancers including non-small-cell lung cancer (NSCLC) remains to be investigated. Here, 12 mtPCD patterns were analyzed in transcriptomics, genomics, and clinical data collected from 4 datasets containing 977 patients. A risk-score assessment system containing 18 genes was established. We found that NSCLC patients with a high-risk score had a poorer prognosis. A nomogram was constructed by incorporating the risk score with clinical features. The risk score was further associated with clinicopathological information, tumor-mutation frequency, and immunotherapy responses. NSCLC patients with a high risk score had more Treg cells infiltration. However, these patients had higher tumor-mutation burden scores and may be more sensitive to immunotherapy. Moreover, receptor-interacting serine/threonine protein kinase 2 (RIPK2) was selected from mtPCD gene model for validation. We found that RIPK2 exhibited oncogenic function, and its expression level was inversely associated with the overall survival of NSCLC. Taken together, our results indicated the accuracy and practicability of the mtPCD gene model and RIPK2 in predicting the prognosis of NSCLC.

线粒体是引发细胞程序性死亡(PCD)的多种途径的汇集点。线粒体相关 PCD(mtPCD)与多种疾病的发病机制有关。然而,mtPCD在包括非小细胞肺癌(NSCLC)在内的癌症预后预测中的作用仍有待研究。本文分析了从包含977名患者的4个数据集中收集的转录组学、基因组学和临床数据中的12种mtPCD模式。建立了包含 18 个基因的风险评分评估系统。我们发现,高风险评分的 NSCLC 患者预后较差。通过将风险评分与临床特征相结合,我们构建了一个提名图。风险评分进一步与临床病理信息、肿瘤突变频率和免疫治疗反应相关联。高风险评分的NSCLC患者有更多的Treg细胞浸润。不过,这些患者的肿瘤突变负荷评分较高,可能对免疫疗法更敏感。此外,我们还从mtPCD基因模型中选取了受体相互作用丝氨酸/苏氨酸蛋白激酶2(RIPK2)进行验证。我们发现,RIPK2具有致癌功能,其表达水平与NSCLC的总生存率成反比。综上所述,我们的研究结果表明,mtPCD基因模型和RIPK2在预测NSCLC预后方面具有准确性和实用性。
{"title":"Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer.","authors":"Xueyan Shi, Sichong Han, Guizhen Wang, Guangbiao Zhou","doi":"10.1007/s11684-024-1093-3","DOIUrl":"https://doi.org/10.1007/s11684-024-1093-3","url":null,"abstract":"<p><p>Mitochondria are the convergence point of multiple pathways that trigger programmed cell death (PCD). Mitochondrial-associated PCD (mtPCD) is involved in the pathogenesis of several diseases. However, the role of mtPCD in the prognostic prediction of cancers including non-small-cell lung cancer (NSCLC) remains to be investigated. Here, 12 mtPCD patterns were analyzed in transcriptomics, genomics, and clinical data collected from 4 datasets containing 977 patients. A risk-score assessment system containing 18 genes was established. We found that NSCLC patients with a high-risk score had a poorer prognosis. A nomogram was constructed by incorporating the risk score with clinical features. The risk score was further associated with clinicopathological information, tumor-mutation frequency, and immunotherapy responses. NSCLC patients with a high risk score had more Treg cells infiltration. However, these patients had higher tumor-mutation burden scores and may be more sensitive to immunotherapy. Moreover, receptor-interacting serine/threonine protein kinase 2 (RIPK2) was selected from mtPCD gene model for validation. We found that RIPK2 exhibited oncogenic function, and its expression level was inversely associated with the overall survival of NSCLC. Taken together, our results indicated the accuracy and practicability of the mtPCD gene model and RIPK2 in predicting the prognosis of NSCLC.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1